HK1043389A1 - 可與人類呼吸道胰蛋白酶類蛋白酶結合的抗體以及其利用方法 - Google Patents

可與人類呼吸道胰蛋白酶類蛋白酶結合的抗體以及其利用方法

Info

Publication number
HK1043389A1
HK1043389A1 HK02105137.1A HK02105137A HK1043389A1 HK 1043389 A1 HK1043389 A1 HK 1043389A1 HK 02105137 A HK02105137 A HK 02105137A HK 1043389 A1 HK1043389 A1 HK 1043389A1
Authority
HK
Hong Kong
Prior art keywords
enzyme
utilization
antibody binding
human airway
airway trypsin
Prior art date
Application number
HK02105137.1A
Other languages
English (en)
Inventor
江口廣志
山岡一良
小川弘子
安岡劭
Original Assignee
帝人株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 帝人株式會社 filed Critical 帝人株式會社
Publication of HK1043389A1 publication Critical patent/HK1043389A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/976—Trypsin; Chymotrypsin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK02105137.1A 1999-12-06 2002-07-10 可與人類呼吸道胰蛋白酶類蛋白酶結合的抗體以及其利用方法 HK1043389A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34589099 1999-12-06
PCT/JP2000/008579 WO2001042450A1 (fr) 1999-12-06 2000-12-04 Anticorps se liant a l'enzyme du type trypsine des voies aeriennes humaines et son utilisation

Publications (1)

Publication Number Publication Date
HK1043389A1 true HK1043389A1 (zh) 2002-09-13

Family

ID=18379692

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105137.1A HK1043389A1 (zh) 1999-12-06 2002-07-10 可與人類呼吸道胰蛋白酶類蛋白酶結合的抗體以及其利用方法

Country Status (8)

Country Link
US (1) US20030073148A1 (zh)
EP (1) EP1152057A4 (zh)
KR (1) KR20010101941A (zh)
CN (1) CN1339064A (zh)
AU (1) AU1651601A (zh)
CA (1) CA2362649A1 (zh)
HK (1) HK1043389A1 (zh)
WO (1) WO2001042450A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001270638A1 (en) * 2000-07-19 2002-01-30 Bayer Aktiengesellschaft Regulation of human airway trypsin protease-like enzyme
WO2002018562A1 (fr) * 2000-08-28 2002-03-07 Teijin Limited Enzymes de type trypsine propres aux voies respiratoires et leur procede d'utilisation
DE10258051A1 (de) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2839825B2 (ja) * 1993-08-30 1998-12-16 帝人株式会社 新規トリプシン様酵素
ATE171728T1 (de) * 1994-07-29 1998-10-15 Teijin Ltd Trypsintyp-enzyme, dafür kodierende nukleinsäuresequenz und verfahren zur herstellung des enzymes

Also Published As

Publication number Publication date
US20030073148A1 (en) 2003-04-17
EP1152057A1 (en) 2001-11-07
CA2362649A1 (en) 2001-06-14
AU1651601A (en) 2001-06-18
EP1152057A4 (en) 2004-05-12
CN1339064A (zh) 2002-03-06
KR20010101941A (ko) 2001-11-15
WO2001042450A1 (fr) 2001-06-14

Similar Documents

Publication Publication Date Title
IL144578A0 (en) Antibodies specific to kdr and uses thereof
GB9911952D0 (en) Improvements in and relating to gratings
GB0312816D0 (en) Improvements in and relating to gratings
EP1323735A4 (en) GENE RELATING TO DRUG TOLERANCE AND USE THEREOF
AU2121200A (en) Improvements in or relating to sphygmomanometers and other devices
GB9916996D0 (en) Improvements in and relating to portable
GB2346163B (en) Improvements in and relating to floors
EP1152057A4 (en) ANTIBODIES BINDING TO THE TRYPSIN-LIKE ENZYME OF HUMAN AIRWAYS AND ITS USE
GB9930507D0 (en) Improvements in and relating to pipes
GB2351333B (en) Improvements in and relating to conduits
GB2347947B (en) Improvements in and relating to guttering
AU3446600A (en) Improvements in and relating to footwear
GB0009471D0 (en) Improvements in and relating to workrests
GB9911322D0 (en) Improvements in and relating to seals
AU7430800A (en) Improvements in and relating to multi-media broadcasting
GB2356341B (en) Improvements in and relating to furniture
GB9914099D0 (en) Improvements in and relating to medicalstents
GB9913039D0 (en) Improvements in and relating to computers
GB9921536D0 (en) Improvements in and relating to multi-media broadcasting
GB9901689D0 (en) Therapeutic antibody composition and use
GB9907151D0 (en) Therapeutic antibody composition and use
GB9906754D0 (en) Therapeutic antibody composition and use
GB9901682D0 (en) Therapeutic antibody composition and use
AU2933600A (en) Improvements in and relating to complexants
GB0130762D0 (en) Improvements in and relating to urine collection